Cargando…
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
The present study was designed to determine the effects of artemisinin (ARS) and its derivatives on human ovarian cancer cells, to evaluate their potential as novel chemotherapeutic agents used alone or in combination with a conventional cancer chemotherapeutic agent, and to investigate their underl...
Autores principales: | Chen, Tao, Li, Mian, Zhang, Ruiwen, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496149/ https://www.ncbi.nlm.nih.gov/pubmed/18466355 http://dx.doi.org/10.1111/j.1582-4934.2008.00360.x |
Ejemplares similares
-
MiR-124-3p.1 Sensitizes Ovarian Cancer Cells to Mitochondrial Apoptosis Induced by Carboplatin
por: Deng, Xiaohong, et al.
Publicado: (2020) -
Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation
por: Zhang, Bicheng, et al.
Publicado: (2018) -
Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
por: Li, Qingrong, et al.
Publicado: (2021) -
Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer
por: Zhang, Yiping, et al.
Publicado: (2018) -
Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin
por: Deng, Minjie, et al.
Publicado: (2019)